BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19406161)

  • 1. Monitoring of human cytomegalovirus glycoprotein B genotypes using real-time quantitative PCR in immunocompromised Chinese patients.
    Fan J; Zhang X; Chen XM; Gao HN; Yang MF; Zhao H; Hu JH; Ma WH
    J Virol Methods; 2009 Sep; 160(1-2):74-7. PubMed ID: 19406161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.
    Mengelle C; Pasquier C; Rostaing L; Sandres-Sauné K; Puel J; Berges L; Righi L; Bouquies C; Izopet J
    J Med Virol; 2003 Feb; 69(2):225-31. PubMed ID: 12683412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation within the glycoprotein B and H genes of human cytomegalovirus in solid organ transplant recipients.
    Zhou L; Fan J; Zheng SS; Ma WH
    Transpl Infect Dis; 2007 Mar; 9(1):73-7. PubMed ID: 17313479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genotyping of viral glycoprotein B (gB) in hematopoietic stem cell transplant recipients with active cytomegalovirus infection: analysis of the impact of gB genotypes on the patients' outcome].
    Roubalová K; Strunecký O; Zufanová S; Procházka B; Vitek A
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):92-9. PubMed ID: 20586171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of three polymerase chain reaction tests targeting morphological transforming region II, UL-83 gene and glycoprotein O gene for the detection of human cytomegalovirus genome in clinical specimens of immunocompromised patients in Chennai, India.
    Sowmya P; Madhavan HN; Therese KL
    Virol J; 2006 Mar; 3():20. PubMed ID: 16571138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of human cytomegalovirus infection in immunosuppressed patients using real-time PCR on whole blood.
    Deback C; Fillet AM; Dhedin N; Barrou B; Varnous S; Najioullah F; Bricaire F; Agut H
    J Clin Virol; 2007 Nov; 40(3):173-9. PubMed ID: 17904901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
    Gouarin S; Vabret A; Gault E; Petitjean J; Regeasse A; Hurault de Ligny B; Freymuth F
    J Clin Virol; 2004 Mar; 29(3):194-201. PubMed ID: 14962789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human cytomegalovirus (HCMV) gB genotypes in Thai patients.
    Bhattarakosol P; Chantaraarphonkun S
    Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):835-40. PubMed ID: 18041299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and application of a novel multiplex polymerase chain reaction for semi-quantitation of human Cytomegalovirus in clinical specimens.
    Madhavan HN; Sowmya P; Therese KL; Malathi J
    J Virol Methods; 2007 May; 141(2):166-72. PubMed ID: 17222918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of mixed infections by multiple genotypes of human cytomegalovirus in immunocompromised patients.
    Sowmya P; Madhavan HN
    J Med Virol; 2009 May; 81(5):861-9. PubMed ID: 19319939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
    Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
    J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus (HCMV) genotype populations in immunocompetent individuals during primary HCMV infection.
    Görzer I; Kerschner H; Redlberger-Fritz M; Puchhammer-Stöckl E
    J Clin Virol; 2010 Jun; 48(2):100-3. PubMed ID: 20362496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations.
    Arista S; De Grazia S; Giammanco GM; Di Carlo P; Iannitto E
    Arch Virol; 2003 Mar; 148(3):547-54. PubMed ID: 12607105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients.
    Coaquette A; Bourgeois A; Dirand C; Varin A; Chen W; Herbein G
    Clin Infect Dis; 2004 Jul; 39(2):155-61. PubMed ID: 15307021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
    Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay.
    Pang X; Humar A; Preiksaitis JK
    J Clin Microbiol; 2008 Dec; 46(12):4004-10. PubMed ID: 18971365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.